Cited by 510RNA Research and SplicingGenetic Neurodegenerative DiseasesMuscle Physiology and Disorders

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy

Lin, Xiaoyan, Miller, Jill W., Mankodi, Ami, Kanadia, Rahul N., Yuan, Yuan, Moxley, Richard T., Swanson, Maurice S., Thornton, Charles A.·2006·Human Molecular Genetics

DOI 10.1093/hmg/ddl132

Open this paper in CoChat — free account

Abstract

In myotonic dystrophy (DM), expression of RNA containing expanded CUG or CCUG repeats leads to misregulated alternative splicing of pre-mRNA. The repeat-bearing transcripts accumulate in nuclear foci, together with proteins in the muscleblind family, MBNL1 and MBNL2. In transgenic mice that express expanded CUG repeats, we show that the splicing defect selectively targets a group of exons that share a common temporal pattern of developmental regulation. These exons undergo a synchronized splicing switch between post-natal day 2 and 20 in wild-type mice. During this post-natal interval, MBNL1 protein translocates from a predominantly cytoplasmic to nuclear distribution. In the absence of MBNL1, these physiological splicing transitions do not occur. The splicing defect induced by expanded CUG repeats in mature muscle fibers is closely reproduced by deficiency of MBNL1 but not by deficiency of MBNL2. A parallel situation exists in human DM type 1 and type 2. MBNL1 is depleted from the muscle nucleoplasm because of sequestration in nuclear foci, and the associated splicing defects are remarkably similar to those observed in MBNL1 knockout mice. These results indicate that MBNL1 participates in the post-natal remodeling of skeletal muscle by controlling a key set of developmentally regulated splicing switches. Sequestration of MBNL1, and failure to maintain these splicing transitions, has a pivotal role in the pathogenesis of muscle disease in DM.

Integrity signals

Registry

Crossref · 10.1093/hmg/ddl132

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member
Brook, J. D., McCurrach, M. E., Harley, H. G., Buckler, A., Church, D. M., Aburatani, H., Hunter, K. W., Stanton, V. P., Thirion, J., Hudson, T. J., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90154-5 · Cited by 2,754
Ultraconserved Elements in the Human Genome
Bejerano, G., Pheasant, M., Makunin, I., Stephen, S., Kent, W. J., Mattick, J. S., & Haussler, D. (2004) · Science · doi:10.1126/science.1098119 · Cited by 1,732
Myotonic Dystrophy Type 2 Caused by a CCTG Expansion in Intron 1 of ZNF9
Liquori, C. L., Ricker, K., Moseley, M. L., Jacobsen, J. F., Kreß, W., Naylor, S. L., Day, J., & Ranum, L. P. W. (2001) · Science · doi:10.1126/science.1062125 · Cited by 1,254
Recruitment of human muscleblind proteins to (CUG)n expansions associated with myotonic dystrophy
Miller, J. W., Urbinati, C. R., Teng‐umnuay, P., Stenberg, M. G., Byrne, B. J., Thornton, C. A., & Swanson, M. S. (2000) · The EMBO Journal · doi:10.1093/emboj/19.17.4439 · Cited by 937
Self-citation
Disruption of Splicing Regulated by a CUG-Binding Protein in Myotonic Dystrophy
Philips, A. V., Timchenko, L., & Cooper, T. A. (1998) · Science · doi:10.1126/science.280.5364.737 · Cited by 818
The Polo kinase Plk4 functions in centriole duplication
Habedanck, R., Stierhof, Y., Wilkinson, C. J., & Nigg, E. A. (2005) · Nature Cell Biology · doi:10.1038/ncb1320 · Cited by 809
Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy
Savkur, R. S., Philips, A. V., & Cooper, T. A. (2001) · Nature Genetics · doi:10.1038/ng704 · Cited by 795
A Muscleblind Knockout Model for Myotonic Dystrophy
Kanadia, R. N., Johnstone, K. A., Mankodi, A., Lungu, C., Thornton, C. A., Esson, D., Timmers, A. M., Hauswirth, W. W., & Swanson, M. S. (2003) · Science · doi:10.1126/science.1088583 · Cited by 743
Self-citation
Myotonic Dystrophy in Transgenic Mice Expressing an Expanded CUG Repeat
Mankodi, A. K., Logigian, E. L., Callahan, L. M., McClain, C., White, R. J., Henderson, D., Krym, M., & Thornton, C. A. (2000) · Science · doi:10.1126/science.289.5485.1769 · Cited by 738
Self-citation
Expanded CUG Repeats Trigger Aberrant Splicing of ClC-1 Chloride Channel Pre-mRNA and Hyperexcitability of Skeletal Muscle in Myotonic Dystrophy
Mankodi, A. K., Takahashi, M. P., Jiang, H. N., Beck, C. L., Bowers, W. J., Moxley, R. T., Cannon, S. C., & Thornton, C. A. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00563-4 · Cited by 672
Self-citation

Show all 35 references

Sorted by citations

Items 201–300 of 509

The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1Preprint
Welte, T., Tuck, A., Papasaikas, P., Carl, S. H., Flemr, M., Knuckles, P., Rankova, A., Bühler, M., & Großhans, H. (2019) · Genes & Development · doi:10.1101/gad.328492.119 · Cited by 45
Aberrant splicing in neurological diseases
Feng, D., & Xie, J. (2013) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1184 · Cited by 44
Muscleblind, BSF and TBPH are mislocalized in the muscle sarcomere of aDrosophilamyotonic dystrophy model
Llamusí, B., Bargiela, A., Fernández‐Costa, J. M., García-López, A., Klima, R., Feiguin, F. M., & Artero, R. D. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.009563 · Cited by 44
Alternative RNA Splicing in the Pathogenesis of Liver Disease
Webster, N. J. G. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00133 · Cited by 44
Dysregulation of Circular RNAs in Myotonic Dystrophy Type 1
Voellenkle, C., Perfetti, A., Carrara, M., Fuschi, P., Renna, L. V., Longo, M., Sain, S. B., Cardani, R., Valaperta, R., Silvestri, G., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081938 · Cited by 48
Features of Modularly Assembled Compounds That Impart Bioactivity Against an RNA Target
Rzuczek, S. G., Gao, Y., Tang, Z., Thornton, C. A., Kodadek, T. J., & Disney, M. D. (2013) · ACS Chemical Biology · doi:10.1021/cb400265y · Cited by 43
Self-citation
Overexpression of CUGBP1 in Skeletal Muscle from Adult Classic Myotonic Dystrophy Type 1 but Not from Myotonic Dystrophy Type 2
Cardani, R., Bugiardini, E., Renna, L. V., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083777 · Cited by 43
Myotonic dystrophy type 2 and modifier genes: an update on clinical and pathomolecular aspects
Meola, G., & Cardani, R. (2017) · Neurological Sciences · doi:10.1007/s10072-016-2805-5 · Cited by 42
Therapeutic Potential of AntagomiR-23b for Treating Myotonic Dystrophy
Cerro-Herreros, E., González-Martínez, I., Moreno-Cervera, N., Overby, S. J., Pérez‐Alonso, M., Llamusí, B., & Artero, R. D. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.07.021 · Cited by 42
Drosophila Muscleblind Is Involved in troponin T Alternative Splicing and Apoptosis
Vicente-Crespo, M., Pascual, M., Fernández‐Costa, J. M., García-López, A., Monferrer, L., Miranda, M. E., Zhou, L. J., & Artero, R. D. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001613 · Cited by 45
Alternative splicing of myomesin 1 gene is aberrantly regulated in myotonic dystrophy type 1
Koebis, M., Ohsawa, N., Kino, Y., Sasagawa, N., Nishino, I., & Ishiura, S. (2011) · Genes to Cells · doi:10.1111/j.1365-2443.2011.01542.x · Cited by 41
Small Molecules Which Improve Pathogenesis of Myotonic Dystrophy Type 1
López-Morató, M., Brook, J. D., & Wojciechowska, M. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00349 · Cited by 41
A cross-sectional study for glucose intolerance of myotonic dystrophy
Matsumura, T., Iwahashi, H., Funahashi, T., Takahashi, M. P., Saito, T., Yasui, K., Saito, T., Iyama, A., Toyooka, K., Fujimura, H., et al. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.08.037 · Cited by 41
Myotonic Dystrophy and Developmental Regulation of RNA Processing
Thomas, J. D., Oliveira, R., Sznajder, Ł. J., & Swanson, M. S. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170002 · Cited by 51
Self-citation
Insulin Receptor Isoforms and Insulin Growth Factor-like Receptors: Implications in Cell Signaling, Carcinogenesis, and Chemoresistance
Galal, M. A., Alouch, S. S., Alsultan, B. S., Dahman, H., Alyabis, N. A., Alammar, S., & Aljada, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241915006 · Cited by 45
RNA Splicing Is Responsive to MBNL1 Dose
Jog, S. P., Paul, S., Dansithong, W., Tring, S., Comai, L., & Reddy, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048825 · Cited by 40
Reversal of RNA toxicity in myotonic dystrophy via a decoy RNA-binding protein with high affinity for expanded CUG repeats
Arandel, L., Matłoka, M., Klein, A. F., Rau, F., Sureau, A., Ney, M., Cordier, A., Kondili, M., Espinoza, M. P., Naouar, N., et al. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00838-2 · Cited by 40
Zebrafish deficient for Muscleblind-like 2 exhibit features of myotonic dystrophy
Machuca-Tzili, L. E., Buxton, S., Thorpe, A., et al. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.004150 · Cited by 39
Na+ Dysregulation Coupled with Ca2+ Entry through NCX1 Promotes Muscular Dystrophy in Mice
Burr, A. R., Millay, D. P., Goonasekera, S. A., Park, K. H., Sargent, M. A., Collins, J. J., Altamirano, F. J., Philipson, K. D., Allen, P. D., Ma, J., et al. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00339-14 · Cited by 38
Myoediting: Toward Prevention of Muscular Dystrophy by Therapeutic Genome Editing
Zhang, Y., Long, C., Bassel‐Duby, R., & Olson, E. N. (2018) · Physiological Reviews · doi:10.1152/physrev.00046.2017 · Cited by 42
Scaffolds and chaperones in myofibril assembly: putting the striations in striated muscle
Crawford, G. L., & Horowits, R. (2011) · Biophysical Reviews · doi:10.1007/s12551-011-0043-x · Cited by 39
RNA Foci, CUGBP1, and ZNF9 Are the Primary Targets of the Mutant CUG and CCUG Repeats Expanded in Myotonic Dystrophies Type 1 and Type 2
Jones, K. R., Jin, B., Iakova, P. A., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.07.013 · Cited by 38
Transcriptional changes and developmental abnormalities in a zebrafish model of myotonic dystrophy type 1
Todd, P. K., Ackall, F. Y., Hur, J., Sharma, K., Paulson, H. L., & Dowling, J. J. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.012427 · Cited by 37
Altered Ca2+ Homeostasis and Endoplasmic Reticulum Stress in Myotonic Dystrophy Type 1 Muscle Cells
Botta, A., Malena, A., Loro, E., et al. (2013) · Genes · doi:10.3390/genes4020275 · Cited by 37
Reduced cytoplasmic MBNL1 is an early event in a brain-specific mouse model of myotonic dystrophy
Wang, P.-Y., Lin, Y.-M., Wang, L., Kuo, T., Cheng, S., & Wang, G. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx115 · Cited by 37
Alternative splicing of PDLIM3/ALP, for α-actinin-associated LIM protein 3, is aberrant in persons with myotonic dystrophy
Ohsawa, N., Koebis, M., Suo, S., et al. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.04.106 · Cited by 37
Cooperation meets competition in microRNA-mediated DMPK transcript regulation
Kościańska, E., Witkos, T. M., Kozłowska, E., Wojciechowska, M., & Krzyżosiak, W. J. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv849 · Cited by 40
Epigenetics and Triplet-Repeat Neurological Diseases
Nageshwaran, S., & Festenstein, R. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00262 · Cited by 36
The RNA-binding protein Staufen1 impairs myogenic differentiation via a c-myc–dependent mechanism
Ravel‐Chapuis, A., Crawford, T. E., Blais-Crépeau, M.-L., et al. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-04-0895 · Cited by 35
Epigenetic changes and non-coding expanded repeats
Nakamori, M., & Thornton, C. A. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.02.004 · Cited by 36
Self-citation
Altered RNA splicing contributes to skeletal muscle pathology in Kennedy disease knock-in mice
Yu, Z., Wang, A. M., Robins, D. M., & Lieberman, A. P. (2009) · Disease Models & Mechanisms · doi:10.1242/dmm.003301 · Cited by 36
Misregulation of calcium-handling proteins promotes hyperactivation of calcineurin–NFAT signaling in skeletal muscle of DM1 mice
Ravel‐Chapuis, A., Bélanger, G., Côté, J., Michel, R. N., & Jasmin, B. J. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx109 · Cited by 35
Most expression and splicing changes in myotonic dystrophy type 1 and type 2 skeletal muscle are shared with other muscular dystrophies
Bachinski, L. L., Baggerly, K., Neubauer, V. L., Nixon, T. J., Raheem, O., Sirito, M., Unruh, A. K., Zhang, J., Nagarajan, L., Timchenko, L., et al. (2013) · Neuromuscular Disorders · doi:10.1016/j.nmd.2013.11.001 · Cited by 34
Chronic exercise mitigates disease mechanisms and improves muscle function in myotonic dystrophy type 1 mice
Manta, A., Stouth, D. W., Xhuti, D., Chi, L., Rebalka, I. A., Kalmar, J. M., Hawke, T. J., & Ljubicic, V. (2019) · The Journal of Physiology · doi:10.1113/jp277123 · Cited by 36
RNA-Binding Protein Misregulation in Microsatellite Expansion Disorders
Goodwin, M., & Swanson, M. S. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-1221-6_10 · Cited by 33
Self-citation
Nucleic acids as templates and catalysts in chemical reactions: target-guided dynamic combinatorial chemistry and in situ click chemistry and DNA/RNA induced enantioselective reactions
Saha, P., Panda, D., & Dash, J. (2023) · Chemical Society Reviews · doi:10.1039/d3cs00166k · Cited by 38
LDB3 splicing abnormalities are specific to skeletal muscles of patients with myotonic dystrophy type 1 and alter its PKC binding affinity
Yamashita, Y., Matsuura, T., Kurosaki, T., Amakusa, Y., Kinoshita, M., Ibi, T., Sahashi, K., & Ohno, K. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.05.026 · Cited by 34
Repeat-associated RNA structure and aberrant splicing
Hale, M. A., Johnson, N. E., & Berglund, J. A. (2019) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2019.07.006 · Cited by 35
MBNL142 and MBNL143 gene isoforms, overexpressed in DM1-patient muscle, encode for nuclear proteins interacting with Src family kinases
Botta, A., Malena, A., Tibaldi, E. V., Rocchi, L., Loro, E., Pena, E., Cenci, L., Ambrosi, E., Bellocchi, M. C., Pagano, M. A., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.291 · Cited by 33
Progressive Cl− channel defects reveal disrupted skeletal muscle maturation in R6/2 Huntington’s mice
Miranda, D. R., Wong, M., Romer, S. H., et al. (2016) · The Journal of General Physiology · doi:10.1085/jgp.201611603 · Cited by 33
Distinct pathological signatures in human cellular models of myotonic dystrophy subtypes
Kim, E. Y., Barefield, D. Y., Vo, A. H., Gacita, A. M., Schuster, E. J., Wyatt, E. J., Davis, J. L., Dong, B., Sun, C., Page, P., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.122686 · Cited by 33
Dosage effect of multiple genes accounts for multisystem disorder of myotonic dystrophy type 1
Yin, Q., Wang, H., Li, N., Ding, Y., Xie, Z., Jin, L., Li, Y., Wang, Q., Liu, X., Xu, L., et al. (2019) · Cell Research · doi:10.1038/s41422-019-0264-2 · Cited by 33
Nanomedicine for Gene Delivery and Drug Repurposing in the Treatment of Muscular Dystrophies
Andreana, I., Repellin, M., Carton, F., Kryza, D., Briançon, S., Chazaud, B., Mounier, R., Arpicco, S., Malatesta, M., Stella, B., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13020278 · Cited by 34
Evaluating the effects of CELF1 deficiency in a mouse model of RNA toxicity
Kim, Y. K., Mandal, M., Yadava, R. S., Paillard, L., & Mahadevan, M. S. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt419 · Cited by 33
Perspectives on gene therapy in myotonic dystrophy type 1
Magaña, J. J., & Cisneros, B. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22551 · Cited by 34
RNA splicing analysis in genomic medicine
Wai, H. A., Douglas, A. G. L., & Baralle, D. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.12.009 · Cited by 33
Alternative Splicing of Transcription Factors Genes in Muscle Physiology and Pathology
Imbriano, C., & Molinari, S. (2018) · Genes · doi:10.3390/genes9020107 · Cited by 35
Muscleblind isoforms are functionally distinct and regulate α-actinin splicing
Vicente-Crespo, M., Monferrer, L., Poulos, M. G., et al. (2007) · Differentiation · doi:10.1111/j.1432-0436.2006.00156.x · Cited by 32
Self-citation
The Alternative Splicing Factor, MBNL1, Inhibits Glioblastoma Tumor Initiation and Progression by Reducing Hypoxia-Induced Stemness
Voss, D. M., Sloan, A. R., Spina, R., Ames, H. M., & Bar, E. E. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-1233 · Cited by 31
Myotonic dystrophy type 2: the 2020 update.
Meola, G. (2020) · PubMed Central · doi:10.36185/2532-1900-026 · Cited by 31
iPSC-derived cardiomyocytes from patients with myotonic dystrophy type 1 have abnormal ion channel functions and slower conduction velocities
Poulin, H., Mercier, A., Djemai, M., Pouliot, V., Deschênes, I., Boutjdir, M., Puymirat, J., & Chahine, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-82007-8 · Cited by 31
CRISPR gene editing in pluripotent stem cells reveals the function of MBNL proteins during humanin vitromyogenesis
Mérien, A., Tahraoui‐Bories, J., Cailleret, M., Dupont, J.-B., Leteur, C., Polentes, J., Carteron, A., Polvèche, H., Concordet, J., Pinset, C., et al. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab218 · Cited by 33
Ribonuclear inclusions and MBNL1 nuclear sequestration do not affect myoblast differentiation but alter gene splicing in myotonic dystrophy type 2
Cardani, R., Baldassa, S., Botta, A., et al. (2009) · Neuromuscular Disorders · doi:10.1016/j.nmd.2009.03.002 · Cited by 31
Protein sequestration as a normal function of long noncoding RNAs and a pathogenic mechanism of RNAs containing nucleotide repeat expansions
Morriss, G. R., & Cooper, T. A. (2017) · Human Genetics · doi:10.1007/s00439-017-1807-6 · Cited by 34
Molecular Effects of the CTG Repeats in Mutant Dystrophia Myotonica Protein Kinase Gene
Llamusí, B., & Artero, R. D. (2008) · Current Genomics · doi:10.2174/138920208786847944 · Cited by 30
Dynamic changes of nuclear RNA foci in proliferating DM1 cells
Xia, G., & Ashizawa, T. (2015) · Histochemistry and Cell Biology · doi:10.1007/s00418-015-1315-5 · Cited by 30
Deprivation of Muscleblind-Like Proteins Causes Deficits in Cortical Neuron Distribution and Morphological Changes in Dendritic Spines and Postsynaptic Densities
Lee, K., Chang, H., Seah, C., & Lee, L. (2019) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2019.00075 · Cited by 33
Altered expression and splicing of Ca2+ metabolism genes in myotonic dystrophies DM1 and DM2
Vihola, A., Sirito, M., Bachinski, L. L., Raheem, O., Screen, M., Suominen, T., Krahe, R., & Udd, B. (2012) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2012.01289.x · Cited by 30
Small molecule kinase inhibitors alleviate different molecular features of myotonic dystrophy type 1
Wojciechowska, M., Taylor, K., Sobczak, K., et al. (2014) · RNA Biology · doi:10.4161/rna.28799 · Cited by 29
Expression and alternative splicing of N‐RAP during mouse skeletal muscle development
Lu, S., Borst, D. E., & Horowits, R. (2008) · Cell Motility and the Cytoskeleton · doi:10.1002/cm.20317 · Cited by 29
Tau exon 2 responsive elements deregulated in myotonic dystrophy type I are proximal to exon 2 and synergistically regulated by MBNL1 and MBNL2
Carpentier, C., Ghanem, D., Fernández-Gómez, F.-J., Jumeau, F., Philippe, J.-V., Freyermuth, F., Labudeck, A., Eddarkaoui, S., Dhaenens, C., Holt, I., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.01.004 · Cited by 29
Manumycin A corrects aberrant splicing of Clcn1 in myotonic dystrophy type 1 (DM1) mice
Oana, K., Oma, Y., Suo, S., Takahashi, M. P., Nishino, I., Takeda, S., & Ishiura, S. (2013) · Scientific Reports · doi:10.1038/srep02142 · Cited by 28
Ultrasound-enhanced delivery of Morpholino with Bubble liposomes ameliorates the myotonia of myotonic dystrophy model mice
Koebis, M., Kiyatake, T., YAMAURA, H., et al. (2013) · Scientific Reports · doi:10.1038/srep02242 · Cited by 28
The Splice Index as a prognostic biomarker of strength and function in myotonic dystrophy type 1
Provenzano, M., Ikegami, K., Bates, K., Gaynor, A., Hartman, J. M., Jones, A. S., Butler, A., Berggren, K. N., Dekdebrun, J. M., Hung, M., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci185426 · Cited by 27
Self-citation
Muscleblind-like 3 deficit results in a spectrum of age-associated pathologies observed in myotonic dystrophy
Choi, J., Dixon, D. M., Dansithong, W., et al. (2016) · Scientific Reports · doi:10.1038/srep30999 · Cited by 27
Non-invasive monitoring of alternative splicing outcomes to identify candidate therapies for myotonic dystrophy type 1
Hu, N., Antoury, L., Baran, T. M., Mitra, S., Bennett, C. F., Rigo, F., Foster, T. H., & Wheeler, T. M. (2018) · Nature Communications · doi:10.1038/s41467-018-07517-y · Cited by 27
Celf1 regulates cell cycle and is partially responsible for defective myoblast differentiation in myotonic dystrophy RNA toxicity
Peng, X., Shen, X., Chen, X., Liang, R., Azares, A. R., & Liu, Y. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.04.010 · Cited by 27
Alternative splicing mediates the compensatory upregulation of MBNL2 upon MBNL1 loss-of-function
Nitschke, L., Hu, R.-C., Miller, A. N., Lucas, L., & Cooper, T. A. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkac1219 · Cited by 30
Repression of nuclear CELF activity can rescue CELF-regulated alternative splicing defects in skeletal muscle models of myotonic dystrophy
Berger, D. S., & Ladd, A. N. (2012) · PLoS Currents · doi:10.1371/currents.rrn1305 · Cited by 26
RNA-binding proteins RBM20 and PTBP1 regulate the alternative splicing of FHOD3
Lorenzi, P., Sangalli, A., Fochi, S., Molin, A. D., Malerba, G., Zipeto, D., & Romanelli, M. G. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.11.009 · Cited by 26
Dynamics and variability of transcriptomic dysregulation in congenital myotonic dystrophy during pediatric development
Hale, M. A., Bates, K., Provenzano, M., & Johnson, N. E. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac254 · Cited by 25
Genome Wide Identification of Aberrant Alternative Splicing Events in Myotonic Dystrophy Type 2
Perfetti, A., Greco, S., Fasanaro, P., Bugiardini, E., Cardani, R., Manteiga, J. M. G., Riba, M., Cittaro, D., Stupka, E., Meola, G., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093983 · Cited by 25
Muscleblind-Like 1 and Muscleblind-Like 3 Depletion Synergistically Enhances Myotonia by Altering Clc-1 RNA Translation
Choi, J., Personius, K. E., DiFranco, M., Dansithong, W., Yu, C., Srivastava, S., Dixon, D. M., Bhatt, D. B., Comai, L., Vergara, J. L., et al. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.07.028 · Cited by 25
Computational Investigation of RNA C U G Repeats Responsible for Myotonic Dystrophy 1
Yildirim, I., Chakraborty, D., Disney, M. D., Wales, D. J., & Schatz, G. C. (2015) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.5b00728 · Cited by 25
Cell-free cloning of highly expanded CTG repeats by amplification of dimerized expanded repeats
Osborne, R. J., & Thornton, C. A. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkn025 · Cited by 27
Self-citation
Proof of concept of peptide-linked blockmiR-induced MBNL functional rescue in myotonic dystrophy type 1 mouse model
Overby, S. J., Cerro-Herreros, E., González-Martínez, I., Varela, M. A., Seoane-Miraz, D., Jad, Y. E., Raz, R., Møller, T., Pérez‐Alonso, M., Wood, M. J. A., et al. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.02.003 · Cited by 24
Myotonic dystrophy
Mahadevan, M. S. (2012) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328357b0d9 · Cited by 24
High-throughput analysis of the RNA-induced silencing complex in myotonic dystrophy type 1 patients identifies the dysregulation of miR-29c and its target ASB2
Cappella, M., Perfetti, A., Cardinali, B., García-Manteiga, J. M., Carrara, M., Provenzano, C., Fuschi, P., Cardani, R., Renna, L. V., Meola, G., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0769-5 · Cited by 23
MBNL1 overexpression is not sufficient to rescue the phenotypes in a mouse model of RNA toxicity
Yadava, R. S., Kim, Y. K., Mandal, M., Mahadevan, K., Gladman, J. T., Yu, Q. C., & Mahadevan, M. S. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz065 · Cited by 24
A Reversal of Misfortune for Myotonic Dystrophy?
Cooper, T. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmcibr064708 · Cited by 24
Exploiting the CRISPR/Cas9 system to study alternative splicingin vivo: application to titin
Charton, K., Suel, L., Henriques, S. F., Moussu, J.-P., Bovolenta, M., Taillepierre, M., Becker, C., Lipson, K., & Richard, I. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw280 · Cited by 24
(CTG)n repeat-mediated dysregulation of MBNL1 and MBNL2 expression during myogenesis in DM1 occurs already at the myoblast stage
André, L. M., van Cruchten, R. T. P., Willemse, M. P., & Wansink, D. G. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217317 · Cited by 24
Antisense oligonucleotide and adjuvant exercise therapy reverse fatigue in old mice with myotonic dystrophy
Hu, N., Kim, E. J., Antoury, L., Li, J., González-Pérez, P., Rutkove, S. B., & Wheeler, T. M. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.11.014 · Cited by 24
Preclinical characterization of antagomiR-218 as a potential treatment for myotonic dystrophy
Cerro-Herreros, E., González-Martínez, I., Moreno, N., Espinosa-Espinosa, J., Fernández‐Costa, J. M., Colom-Rodrigo, A., Overby, S. J., Seoane-Miraz, D., Poyatos‐García, J., Vilchez, J. J., et al. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.07.017 · Cited by 23
Senescence plays a role in myotonic dystrophy type 1
García-Puga, M., Saenz‐Antoñanzas, A., Gereñu, G., Arrieta-Legorburu, A., Fernández‐Torrón, R., Zulaica, M., Sáenz, A., Elizazu, J., Nogales‐Gadea, G., Gadalla, S. M., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.159357 · Cited by 23
Clinical and Molecular Insights into Gastrointestinal Dysfunction in Myotonic Dystrophy Types 1 & 2
Peterson, J. A. M., & Cooper, T. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314779 · Cited by 24
Myotonic dystrophy RNA toxicity alters morphology, adhesion and migration of mouse and human astrocytes
Dincã, D. M., Lallemant, L., González‐Barriga, A., Cresto, N., Bráz, S., Sicot, G., Pillet, L., Polvèche, H., Magneron, P., Huguet-Lachon, A., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31594-9 · Cited by 23
Identification of Plant-derived Alkaloids with Therapeutic Potential for Myotonic Dystrophy Type I
Herrendorff, R., Faleschini, M. T., Stiefvater, A., Erne, B., Wiktorowicz, T., Kern, F., Hamburger, M. O., Potterat, O., Kinter, J., & Sinnreich, M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.710616 · Cited by 23
Recovery in the Myogenic Program of Congenital Myotonic Dystrophy Myoblasts after Excision of the Expanded (CTG)n Repeat
André, L. M., van Cruchten, R. T. P., Willemse, M. P., Bezstarosti, K., Demmers, J., van Agtmaal, E. L., Wansink, D. G., & Wieringa, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225685 · Cited by 23
HTS-Compatible Patient-Derived Cell-Based Assay to Identify Small Molecule Modulators of Aberrant Splicing in Myotonic Dystrophy Type 1
O’Leary, D. A., Vargas, L., Sharif, O., et al. (2010) · Current Chemical Genomics · doi:10.2174/1875397301004010009 · Cited by 22
CDK12 inhibition reduces abnormalities in cells from patients with myotonic dystrophy and in a mouse model
Ketley, A., Wojciechowska, M., Ghidelli, S., Bamborough, P., Ghosh, T. K., López-Morató, M., Sedehizadeh, S., Malik, N. A., Tang, Z., Powalowska, P. K., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz2415 · Cited by 22
Self-citation
RNA-Binding Proteins in Heart Development
Giudice, J., & Cooper, T. A. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-1221-6_11 · Cited by 23
Myotonic dystrophies: an update on clinical features, molecular mechanisms, management, and gene therapy
Rimoldi, M., Lucchiari, S., Pagliarani, S., Meola, G., Comi, G. P., & Abati, E. (2024) · Neurological Sciences · doi:10.1007/s10072-024-07826-9 · Cited by 27
Integrative Cell Type-Specific Multi-Omics Approaches Reveal Impaired Programs of Glial Cell Differentiation in Mouse Culture Models of DM1
González‐Barriga, A., Lallemant, L., Dincã, D. M., Bráz, S., Polvèche, H., Magneron, P., Pionneau, C., Huguet-Lachon, A., Claude, J., Chhuon, C., et al. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.662035 · Cited by 21
Role of noncoding RNAs in trinucleotide repeat neurodegenerative disorders
Tan, H., Xu, Z., & Jin, P. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.01.019 · Cited by 23
Expression of a Dominant Negative CELF Protein In Vivo Leads to Altered Muscle Organization, Fiber Size, and Subtype
Berger, D. S., Moyer, M., Kliment, G. M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019274 · Cited by 21
Contractile dysfunction in muscle may underlie androgen-dependent motor dysfunction in spinal bulbar muscular atrophy
Oki, K., Halievski, K., Vicente, L., et al. (2015) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00886.2014 · Cited by 21
Paradoxical overexpression of MBNL2 in hepatocellular carcinoma inhibits tumor growth and invasion
Lee, Y.-H., Jhuang, Y., Chen, Y., Jeng, Y., & Yuan, R. (2016) · Oncotarget · doi:10.18632/oncotarget.11577 · Cited by 21
Four parameters increase the sensitivity and specificity of the exon array analysis and disclose 25 novel aberrantly spliced exons in myotonic dystrophy
Yamashita, Y., Matsuura, T., Shinmi, J., Amakusa, Y., Masuda, A., Ito, M., Kinoshita, M., Furuya, H., Abe, K., Ibi, T., et al. (2012) · Journal of Human Genetics · doi:10.1038/jhg.2012.37 · Cited by 21
Dystrophia myotonia: why focus on foci?
Junghans, R. P. (2009) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.227 · Cited by 21

Authors: Lin, X., Miller, J. W., Mankodi, A., Kanadia, R. N., Yuan, Y., Moxley, R. T., Swanson, M. S., & Thornton, C. A.
Affiliations: University of Rochester Medicine (US)
University of Florida (US)
Corresponding author: Thornton, Charles A.
ORCID: Mankodi, Ami
Kanadia, Rahul N.
Yuan, Yuan
Swanson, Maurice S.
Thornton, Charles A.
Venue: Human Molecular Genetics
Publisher: Oxford University Press (OUP)
Published: 2006-05-22
Volume: 15
Issue: 13
Pages: 2087-2097
ISSN: 0964-6906 (ISSN-L)
1460-2083
DOI: 10.1093/hmg/ddl132
OpenAlex: W2140074138
Semantic Scholar: 1b600bfc756195b662624998312e8d206442a550
Cited by: 510
References: 35
Citations by year: 2026: 19 · 2025: 19 · 2024: 20 · 2023: 19 · 2022: 17 · 2021: 27 · 2020: 29 · 2019: 24 · 2018: 27 · 2017: 19 · 2016: 26 · 2015: 27 · 2014: 37 · 2013: 34 · 2012: 36
FWCI: 9.66
Type: journal article
Language: en
Open access: closed
Locations: Human Molecular Genetics (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (n01ar002250-007)
National Institute of Neurological Disorders and Stroke (NS-48843)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR-48143, R01AR049077, K24AR048143, R01AR046799, AR02250, R01AR046806, AR46806)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
Keywords: myotonic dystrophy, MBNL1, MBNL2, CUG repeat expansion, alternative splicing, nuclear foci, skeletal muscle development, myotonic dystrophy type 1, myotonic dystrophy type 2
MeSH terms: Animals, Cell Nucleus, Humans, Mice, Transgenic, Molecular Sequence Data, Myotonic Dystrophy, Time Factors, Immunoblotting, RNA-Binding Proteins, Alternative Splicing, Mice, Knockout, Muscle, Skeletal, Gene Expression Regulation, Developmental, Trinucleotide Repeat Expansion, Reverse Transcriptase Polymerase Chain Reaction, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks